Bank Of New York Mellon Corp Insmed Inc Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$16.26 - $21.73 $40.5 Million - $54.2 Million	2,493,724 New	2,493,724 $42.5 Billion
Q4 2022 Feb 14, 2023	BUY	$16.98 - $23.15 $23 Million - $31.4 Million	1,355,381 New	1,355,381 $27.1 Million
Q3 2022 Nov 14, 2022	BUY	$20.88 - $28.21 $9.19 Million - $12.4 Million	440,161 Added 87.78%	941,582 $20.3 Million
Q2 2022 Aug 15, 2022	SELL	$17.07 - $25.71 $75,927 - $114,358	-4,448 Reduced 0.88%	501,421 $9.89 Million
Q1 2022 May 11, 2022	BUY	$20.42 - $28.13 $35,061 - $48,299	1,717 Added 0.34%	505,869 $11.9 Million
Q4 2021 Feb 11, 2022	BUY	$25.89 - $33.45 $327,146 - $422,674	12,636 Added 2.57%	504,152 $13.7 Million
Q3 2021 Nov 12, 2021	BUY	$22.46 - $29.47 $1.07 Million - $1.4 Million	47,558 Added 10.71%	491,516 $13.5 Million
Q2 2021 Aug 11, 2021	BUY	$24.17 - $36.01 $633,616 - $944,002	26,215 Added 6.28%	443,958 $12.6 Million
Q1 2021 May 13, 2021	SELL	$32.28 - $44.3 $484,845 - $665,386	-15,020 Reduced 3.47%	417,743 $14.2 Million
Q4 2020 Feb 09, 2021	SELL	$31.45 - $40.54 $158,004 - $203,672	-5,024 Reduced 1.15%	432,763 $14.4 Million
Q3 2020 Nov 12, 2020	SELL	$26.0 - $34.5 $276,822 - $367,321	-10,647 Reduced 2.37%	437,787 $14.1 Million
Q2 2020 Aug 12, 2020	BUY	$14.11 - $29.42 $618,314 - $1.29 Million	43,821 Added 10.83%	448,434 $12.3 Million
Q1 2020 May 06, 2020	BUY	$13.63 - $33.98 $64,660 - $161,201	4,744 Added 1.19%	404,613 $6.49 Million
Q4 2019 Feb 14, 2020	BUY	$16.12 - $24.98 $297,011 - $460,256	18,425 Added 4.83%	399,869 $9.55 Million
Q3 2019 Nov 07, 2019	SELL	$15.49 - $25.78 $86,108 - $143,311	-5,559 Reduced 1.44%	381,444 $6.73 Million
Q2 2019 Aug 12, 2019	BUY	$23.0 - $32.19 $173,696 - $243,098	7,552 Added 1.99%	387,003 $9.91 Million
Q1 2019 May 14, 2019	BUY	$13.91 - $31.15 $146,361 - $327,760	10,522 Added 2.85%	379,451 $11 Million
Q4 2018 Feb 11, 2019	BUY	$11.6 - $18.7 $18,641 - $30,050	1,607 Added 0.44%	368,929 $4.84 Million
Q3 2018 Nov 09, 2018	SELL	$18.95 - $28.08 $40,950 - $60,680	-2,161 Reduced 0.58%	367,322 $0
Q2 2018 Aug 06, 2018	SELL	$20.0 - $29.72 $262,000 - $389,332	-13,100 Reduced 3.42%	369,483 $8.74 Million
Q1 2018 May 15, 2018	SELL	$21.69 - $32.99 $816,346 - $1.24 Million	-37,637 Reduced 8.96%	382,583 $8.62 Million
Q4 2017 Feb 09, 2018	BUY	$26.43 - $31.78 $11.1 Million - $13.4 Million	420,220	420,220 $13.1 Million

Others Institutions Holding INSM

# of Institutions

467

Shares Held

182M

Call Options Held

2.27M

Put Options Held

3.33M

Vanguard Group Inc Valley Forge, PA

17.1M
Shares

$1.27 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

14.3M
Shares

$1.05 Billion
0.02% of portfolio
Price T Rowe Associates Inc Baltimore, MD

12.6M
Shares

$929 Million
0.11% of portfolio
Darwin Global Management, Ltd. St. Helier, Y9

10.5M
Shares

$775 Million
62.32% of portfolio
Capital International Investors Los Angeles, CA

6.52M
Shares

$482 Million
0.09% of portfolio

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account